Clarification

09/30/2004

Due to a lack of clarity in the original news report, a summary in Monday's FDLI SmartBrief stated that Purdue Pharma said Palladone, its recently approved analgesic, may be more difficult to misuse than OxyContin. Purdue Pharma says it does not claim that Palladone, which has been approved by the FDA, is abuse-resistant or more difficult to misuse than OxyContin.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT